Ipsen’s Iqirvo wins European approval for primary biliary cholangitis
The approval sets up a showdown between Iqirvo and Intercept’s PBC treatment Ocaliva.
The approval sets up a showdown between Iqirvo and Intercept’s PBC treatment Ocaliva.
What's Your Reaction?
